Important Notice from the EDQM to CEP Holders - Warning of Fraudulent Invoices
Recommendation

Thursday, 3 September 2026 9 .00 - 17.00 h
Establishment, Use and Maintenance of Analytical Reference Substances
In a press release from 21 May 2012, the EDQM (European Directorate for the Quality of Medicines & HealthCare), declared that some CEP holders may have recently received an invoice from an organisation which calls itself "Directory for Certificates of Suitability" (DCEP), asking them to pay a fee to include their CEPs in a "Directory".
The EDQM expressly states that these invoices haven't been sent by the EDQM and that holders of CEPs do not require their CEPs to be registered in any directory.
Find more information on the EDQM Website and in the press release.
Author:
Dr Günter Brendelberger
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
08.07.2026Revised Annex 19 on Reference and Retention Samples
01.07.2026Several FDA Warning Letters and Untitled Letters on Asbestos Testing of Talc in OTC Drug Products
24.06.2026Analytical Quality Group Developments January through April 2026
17.06.2026BioPhorum Publishes a Roadmap for QC Sample Test Execution
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem


